BL Pharmtech Past Earnings Performance
Past criteria checks 0/6
BL Pharmtech's earnings have been declining at an average annual rate of -20.5%, while the Personal Products industry saw earnings growing at 5% annually. Revenues have been declining at an average rate of 1.4% per year.
Key information
-20.5%
Earnings growth rate
-15.2%
EPS growth rate
| Personal Products Industry Growth | 3.8% |
| Revenue growth rate | -1.4% |
| Return on equity | -43.4% |
| Net Margin | -57.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Revenue & Expenses BreakdownBeta
How BL Pharmtech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 24,525 | -14,101 | 20,137 | 0 |
| 30 Sep 23 | 97,367 | -15,558 | 23,172 | 0 |
| 30 Jun 23 | 90,921 | -13,952 | 21,913 | 0 |
| 31 Mar 23 | 82,965 | -13,543 | 20,865 | 0 |
| 31 Dec 22 | 22,523 | -14,690 | 17,166 | 0 |
| 30 Sep 22 | 86,983 | -12,232 | 22,419 | 0 |
| 30 Jun 22 | 82,282 | -12,741 | 23,704 | 0 |
| 31 Mar 22 | 83,757 | -20,524 | 24,162 | 0 |
| 31 Dec 21 | 84,440 | -20,211 | 24,179 | 0 |
| 30 Sep 21 | 82,378 | -26,473 | 22,898 | 0 |
| 30 Jun 21 | 77,279 | -33,182 | 21,924 | 0 |
| 31 Mar 21 | 69,925 | -20,874 | 21,081 | 0 |
| 31 Dec 20 | 65,691 | -17,947 | 21,969 | 0 |
| 30 Sep 20 | 55,847 | -13,488 | 27,987 | 0 |
| 30 Jun 20 | 54,165 | -3,720 | 27,992 | 0 |
| 31 Mar 20 | 53,804 | -9,550 | 28,824 | 0 |
| 31 Dec 19 | 58,869 | -11,820 | 30,132 | 0 |
| 30 Sep 19 | 69,732 | -3,648 | 26,288 | 0 |
| 30 Jun 19 | 80,466 | -5,818 | 30,295 | 0 |
| 31 Mar 19 | 89,062 | 1,245 | 32,574 | 0 |
| 31 Dec 18 | 87,686 | 1,302 | 31,888 | 0 |
| 30 Sep 18 | 84,840 | -1,921 | 34,086 | 0 |
| 30 Jun 18 | 82,673 | -1,120 | 31,237 | 0 |
| 31 Mar 18 | 77,494 | -2,458 | 28,141 | 0 |
| 31 Dec 17 | 83,708 | -3,056 | 26,594 | 0 |
| 30 Sep 17 | 79,549 | -2,717 | 22,365 | 0 |
| 30 Jun 17 | 77,111 | -3,307 | 21,663 | 0 |
| 31 Mar 17 | 83,728 | -5,317 | 24,807 | 0 |
| 31 Dec 16 | 73,963 | -5,076 | 24,700 | 0 |
| 30 Sep 16 | 70,910 | -8,439 | 24,527 | 0 |
| 30 Jun 16 | 67,218 | -8,738 | 24,334 | 0 |
| 31 Mar 16 | 58,819 | -6,259 | 21,168 | 0 |
| 31 Dec 15 | 57,145 | -6,514 | 20,948 | 0 |
| 30 Sep 15 | 56,025 | -1,881 | 20,098 | 0 |
| 30 Jun 15 | 59,532 | -1,426 | 23,129 | 0 |
| 31 Mar 15 | 62,883 | -1,306 | 25,494 | 0 |
| 31 Dec 14 | 61,595 | -1,043 | 25,637 | 0 |
| 30 Sep 14 | 60,724 | -1,385 | 25,750 | 0 |
| 30 Jun 14 | 56,481 | -1,275 | 22,105 | 0 |
| 31 Mar 14 | 52,124 | -1,203 | 20,666 | 0 |
| 31 Dec 13 | 50,703 | -1,608 | 19,339 | 0 |
| 30 Sep 13 | 45,867 | -2,813 | 20,493 | 0 |
| 30 Jun 13 | 48,195 | -3,966 | 21,896 | 0 |
Quality Earnings: A065170 is currently unprofitable.
Growing Profit Margin: A065170 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A065170 is unprofitable, and losses have increased over the past 5 years at a rate of 20.5% per year.
Accelerating Growth: Unable to compare A065170's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A065170 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (38.8%).
Return on Equity
High ROE: A065170 has a negative Return on Equity (-43.43%), as it is currently unprofitable.